COPD Assessment Test Can Predict Depression
Launched by HALLYM UNIVERSITY MEDICAL CENTER · Nov 14, 2012
Trial Information
Current as of August 15, 2025
Unknown status
Keywords
ClinConnect Summary
This study is aimed to investigate the association between the COPD Assessment Test (CAT) and depression in stable COPD patients. Stable COPD patients will be enrolled from the tertiary hospitals. All patients will undergo lung function tests. The Korean versions of the CAT (COPD assessment test) and Patient Health Questionnaire-9 (PHQ-9) will be used to assess COPD symptoms and depressive disorder, respectively.
We will compare the depresssion frequency among GOLD classifications of airway limitation and among the four CAT groups. And. we will also investigate which items of the CAT are t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • COPD patients who aged \> or = 40 years
- Exclusion Criteria:
- • acute exacerbation within 3 months
- • bronchial asthma or an increase in FEV1 of more than 12% of the predicted value with the use of 400 µg of albuterol.
- • other lung diseases such as bronchiectasis, interstitial lung disease, and tuberculosis-destroyed lungs.
- • who denied to consent.
About Hallym University Medical Center
Hallym University Medical Center is a leading healthcare institution in South Korea, renowned for its commitment to advancing medical research and clinical excellence. As a prominent clinical trial sponsor, Hallym University Medical Center leverages its state-of-the-art facilities and multidisciplinary expertise to facilitate innovative research initiatives. The center is dedicated to enhancing patient care through rigorous clinical studies that aim to evaluate new treatments and therapies across various medical fields. With a focus on ethical standards and patient safety, Hallym University Medical Center collaborates with researchers and healthcare professionals to contribute valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Anyang , Gyeonggi Do, Korea, Republic Of
Patients applied
Trial Officials
KI-Suck Jung, Dr.
Principal Investigator
Hallym University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials